Non-peptidyl poststatin analogues, (5)-A^-substituted-2-[2-(l -acylpyrrolidinyl)]-2-oxoacetamides were synthesized and examined for their inhibitory activity against prolyl endopeptidase and cathepsin B in vitro. Many compounds showed stronger activity than natural poststatin, a (22) and (5)
Non-peptidyl poststatin analogues, (5)-A^-substituted-2- [2-(l -acylpyrrolidinyl) ]-2-oxoacetamides were synthesized and examined for their inhibitory activity against prolyl endopeptidase and cathepsin B in vitro. Many compounds showed stronger activity than natural poststatin, a pentapeptide. Amongthem, (5)-7V-cyclohexyl-2-oxo-2- [2-(l -(3-phenoxybenzoyl) pyrrolidinyl)]acetamide (22) and (5)-A^-cyclohexyl-2- [2-( l -(2-naphthoyl) pyrrolidinyl)]-2-oxoacetamide (19) indicated IC50 value of 5.8 and 8.2ng/ml for prolyl endopeptidase inhibition respectively. None of these compounds possess significant inhibitory activities against cathepsin B, a cysteine protease. These results indicate that these compounds are more selective inhibitors against prolyl endopeptidase than is natural poststatin.
Prolyl endopeptidase (PEP) [EC 3.4.21.26 ] is a serine protease1} that is highly active in the brain and degrades proline-containing oligopeptides such as oxytocin, neurotensin, substance P, thyrotropin releasing hormone, bradykinin, and angiotensin II2~7). PEP also degrades vasopressin which has been suggested to play an important role in learning and memory8~10). Moreover, PEP may be involved in processing the C-terminal portion of the amyloid precursor protein in Alzheimer's disease1 1}.
Recently, many potent inhibitors such as benzyloxycarbonyl(Z)-Gly-Pro-CH2Cl1), Z-Pro-prolinal12), l-(iV-(4-phenylbutyryl)-Pro)-pyrrolidine1 3), and related compounds13~19> have been studied, and peptidyl aldehydes and pyrrolidine derivatives have been reported to ameliorate the experimental amnesia induced by scopolamine in rats13jl6).
In the course of our study, poststatin (PST, Fig. 1 ) was isolated as a PEP inhibitor (IC50 = 0.030 fig/ml) from a Streptomyces culture filtrate20~22). Manypeptidyl PST analogues which contain a (iS)-3-amino-2-oxovaleryl moiety in the Px position were synthesized for determination of the structure-activity relationships23). In the preceding paper we have described a potent and selective PEP inhibitor series containing a (S)-2-oxo-2-(2-pyrrolidinyl)acetyl (ProCO) moiety in the Px position. We have also found that P'x in the ProCO containing OCT. 1996 inhibitors was exchangeable to the cyclohexyl (cHx) amine moiety without significant loss of inhibitory activity24). These results encouraged us to design even smaller PEP inhibitors by eliminating the P2-amino acid residue, and our attention was focused on conversion to lower molecular weight and non-peptidyl structures. In this paper, wereport the synthesis of the newseries of PEP inhibitors with a general formula (R2-ProCO-R1(R2=acyl group, Rx =amine)) and their inhibitory activity is contrasted with that of cathepsin B in vitro.
Chemi stry
The synthetic route is outlined in scheme 1. Starting
acetic acid (Boc-or Z-H2ProCO) was prepared from Z-L-proline in five steps according to the procedure described in the previous paper24). The coupling reaction of these acid components with various amine components was performed by the l-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC)-1 -hydroxybenzotriazole (HOBt) method25'26). Removal of the protective group was performed by acid treatment for the Bocgroup and hydrogenation for the Z-group. Introduction of the acyl group was performed by the acid chloride method or the EDC-HOBtmethod. Oxidation of the hydroxyl group of the diastereomeric H2ProCO residue to ketone was performed by the Pfitzner-Moffatt27) or the Albright-Goldman28) method.
Results and Discussion The results obtained are summarizedin Table 1 . Previously we reported the effect of introduction of a cycloalkylamine component on PEP inhibition in aldehyde-type inhibitors24).
To estimate the effect of the Pi cycloalkylamine moiety in the non-peptidyl structure, we prepared compounds havingthree different types of amine (cyclic amine(pyrrolidine (1)), cycloalkylamine (cyclohexylamine (2)), and bulky alkylamine (7-butylamine(3~5))). Among them, the Picycloalkylamino group was found tobe most effective for PEPinhibition and showed nosignificant inhibitory activity for cathepsin B.Thus we selected 2 as a further leadcompound, and the P2 acylgroup of2 was widelyvaried.
Comparison of the compounds having mono-and di-substituted benzoyl groups(o-methyl (6), m-methyl (7),^-methyl (8), 3,5-dimethyl(9) , and 2,6-dimethyl (10)) indicated that the parasubstituted benzoyl group was most potent inthis series.
Introductionof differenttypes of substituents for the para-bznzoyl position ofcompound 8 (chloro-(ll), fluoro-(12), methoxy-(13), and nitro- (14)) indicated that ll and 13 were equipotent, 14 was 2.5-fold less potent and 12 was 5.5-fold less potent than parental 8 in PEP inhibition. The heterocyclic bioisostere of 2 (picolinoyl (15)) was less potent than 8. Wetried to introduce more bulky hydrophobic groups than benzoyl (cinnamoyl (16), 2-naphthoyl (19, 20) , and 3-phenoxybenzoyl (22) ) since we hoped to enhance a putative van der Waals interaction with a S2 subsite of the enzyme. All these compounds gave a 3.5~10-fold increase in potency over parental 2, but introduction of both a basic nitrogen into the aromatic ring (18 vs 16 and 21 vs 19) and a/7-chloro group into cinnamoyl group (17 vs 16) decreased the inhibitory activity.
In summary, a series of acyl-ProCO-amide type compounds showed potent inhibitory activity against PEP in spite of their non-peptidyl and low molecular weight structures and their possession of only one asymmetric center. Amongthem the compounds having a cycloalkylamine component in the Px position was preferable and introduction of 3-phenoxybenzoyl or 2-naphthoyl group in the P2 position was effective.
Experimental

General
Melting points were determined with a micro melting point apparatus and are unconnected. Optical rotations OCT. 1996 were measured with a Perkin-Elmer 241 polarimeter. XH 
to the procedure described in the previous paper24).
acetamide Hydrochloride (2b à" HC1) 2b HCl was prepared from TV-cyclohexyl^-CC.S')^-
-(^*S)-2-hydroxyacetamide (2a) according to the procedure described in the previous paper24).
-(jR5' )-2-hydroxyacetamide (20a) according to the procedure described in the previous paper24).
To an ice-cold solution of Z-H2ProCO24) (745.6mg, 2.67mmol), r-butylamine (301 /d, 2.83 mmol) and HOBt (541.8mg, 4.01 mmol) in DMF (5ml) was added EDO HC1 (716.5mg, 3.74mmol), and the mixture was stirred in an ice bath for 2 hours and then at room temperature for 4 hours. The mixture was diluted with EtOAc (50 ml), and the mixture was washed with 4% aq NaHCO3, saturated aq NaCl, 1% aq citric acid, saturated aq NaCl (each 30ml), and dried (Na2SO4). After removal of the solvent, the product was purified by silica gel column chromatography with CH2Cl2 -EtOAc (7 : 1) to give 3a as a solid, 399.6mg (44.8%): Rf 0.60 (CH2C12 -EtOAc, 7:1), FAB-MS m/z 335 (M+H) +, 291, 245, 201, 160, 91, 70, 57. To a solution of 3b (47.5mg, 0.237mmol) in anhydrous THF (1.0ml) was added triethylamine (42//I, 0.300 mmol), and the solution was treated dropwise with benzoyl chloride (34 /jl, 0.293 mmol) in anhydrous THF (1.5ml) over a period of 30 minutes. The mixture was stirred for additional 2 hours at room temperature, and the solvent wasevaporated. To the mixture was added I n HC1(1.5ml), and the mixture was extracted thrice with EtOAc (each 2ml). The combined extracts were washed with saturated aq NaHCO3(6 ml) and saturated aq NaCl (6ml), and dried (Na2SO4 The compound4c and 5c were prepared from 3b by a similar procedure using 3-phenylpropionyl chloride and cyclohexylcarbonyl chloride, respectively. Af an ice bath for 2 hours and at roomtemperature for 3~21 hours. The completion of the reaction was monitored by TLC. The mixture was diluted with EtOAc, and the mixture was washed with 4% aq NaHCO3, saturated aq NaCl, l~10% aq citric acid (this operation was omitted in case of basic compound), and saturated aq NaCl, and dried (Na2SO4). After removal of the solvent, the product was purified by silica gel column chroma- 
Pfitzner-Moffatt Oxidation (Synthesis of 2 -18)
A mixture of H2ProCOresidue-containing precursor (2c-18c, 1 equiv), pyridinium trifluoroacetate (0.5 equiv), EDC HC1 (3 equiv) and anhydrous DMSO (0.5 -1.3 ml/100mg of substrate) in benzene was stirred at room temperature for 5-17hours. The completion of the reaction was monitored by TLC. The reaction mixture was diluted with EtOAc (10-fold excess of DMSO),and the mixture was washed with water, and dried (Na2SO4). After removal of the solvent, the product was purified by the following method. (2) 3.68 (1H, m, NCHa^), 3.76 (1H, m, 5.41 (1H, dd, J=5.9, 7.9Hz, NCHCOCO), 6.78 (1H, brd, 7=7.9Hz, NH), 7.10 (2H, m, aromatic protons), 7.59 (2H, m, aromatic protons) .
Crude (5r) A mixture of H2ProCOresidue-containing precursor (lc or 19c-22c, 1 equiv) , anhydrous DMSO(0.3ml-l.Oml/lOOmg of substrate) and Ac2O (20 equiv) was stirred at room temperature for 22-24 hours. The OCT. 1996 reaction mixture was diluted with H2O(20-fold excess of DMSO)and stirred for 30 minutes. The mixture was extracted thrice with CH2C12or EtOAc, and the combined extracts were dried (Na2SO4). After removal of the solvent, the product was purified by the following method.
Crude (S> l -{2- [2-(l -benzoylpyrrolidinyl) 
